In this work, nephro- and peripheral neurotoxicity of cyclic repeated CDDP treatment, resembling chemotherapeutic treatment protocol of cancer patients, were studied in WT mice and in mice with genetic deletion only of OCT2 (OCT2−/−) to dissect the importance of this transporter for CDDP unwanted toxicities. The gene discussed is SLC22A2; the disease is cancer.